Immunocore Holdings presented clinical trial data at the ASCO meeting, with stock benefiting from Trump-era tariffs.
1 report, 1 independent
Updated Jun 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Immunocore Holdings presented clinical trial data at the ASCO meeting, with stock benefiting from Trump-era tariffs.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
American Society of Clinical Oncology
organization
Nothing else this week.
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)